Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 6/20 | 0.45 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HRH4 | Q9H3N8 | 4/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL37872 | 0.98 | CXCR4 (0.46) | CXCR4CXCL12KMT2AHRH4HRH3 | |
| SCHEMBL21518374 | 0.98 | CXCR4 (0.46) | CXCR4CXCL12KMT2AHRH4HRH3 | |
| SCHEMBL918578 | 0.98 | CXCR4 (0.46) | CXCR4CXCL12KMT2AHRH4HRH3 | |
| Ammonia Solution, Strong SCHEMBL4735488 | 0.96 | CXCR4 (0.45) | CXCR4CXCL12KMT2AHRH4HRH3 | |
| SCHEMBL31100384 | 0.96 | CXCR4 (0.45) | CXCR4CXCL12KMT2AHRH4HRH3 | |
| Phosphine SCHEMBL28328787 | 0.96 | CXCR4 (0.45) | CXCR4CXCL12KMT2AHRH4HRH3 | |
| SCHEMBL918520 | 0.96 | CXCR4 (0.44) | CXCR4CXCL12KMT2AHRH4HRH3 | |
| Phosphine SCHEMBL28327588 | 0.95 | CXCR4 (0.44) | CXCR4CXCL12KMT2AHRH4HRH3 | |
| SCHEMBL21518399 | 0.94 | CXCR4 (0.46) | CXCR4CXCL12KMT2AHRH4HRH3 | |
| SCHEMBL165817 | 0.94 | CXCR4 (0.46) | CXCR4CXCL12KMT2AHRH4HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117897424-A | Aqueous polyurethane urea dispersions | 科思创德国股份有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-115746252-A | Aqueous polyurethane urea dispersions | 科思创德国股份有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-102827390-A | Polymer film for rapidly detecting mercury, preparation method and application thereof | UNIV BEIJING CHEMICAL | 2012-12-19 | — | — | CN | claimed |
| CN-102079809-B | Organosilicon modified high functionality polyisocyanate and water-based preparation method thereof | HUBEI DEBANG CHEMICAL NEW MATERIALS CO LTD | 2012-10-31 | — | — | CN | claimed |
| CN-102079809-A | Organosilicon modified high functionality polyisocyanate and water-based preparation method thereof | HUBEI DEBANG CHEMICAL NEW MATERIALS CO LTD | 2011-06-01 | — | — | CN | claimed |
| CN-117897424-A | Aqueous polyurethane urea dispersions | 科思创德国股份有限公司 | 2024-04-16 | — | — | CN | disclosed |
| US-20230127229-A1 | MULTI-AZIRIDINE COMPOUND | COVESTRO (NETHERLANDS) B.V. (NL) | 2023-04-27 | — | — | US | disclosed |
| CN-115746252-A | Aqueous polyurethane urea dispersions | 科思创德国股份有限公司 | 2023-03-07 | — | — | CN | disclosed |
| US-20230054196-A1 | MULTI-AZIRIDINE COMPOUND | COVESTRO (NETHERLANDS) B.V. (NL) | 2023-02-23 | — | — | US | disclosed |
| CN-115003719-A | Polyaziridine compounds | 科思创(荷兰)有限公司 | 2022-09-02 | — | — | CN | disclosed |
| CN-114945615-A | Polyaziridine compounds | 科思创(荷兰)有限公司 | 2022-08-26 | — | — | CN | disclosed |
| CN-114736351-A | Blocked isocyanate curing agent, preparation method thereof and baking type coating | 江苏富琪森新材料有限公司 | 2022-07-12 | — | — | CN | disclosed |
| US-20070026504-A1 | METHOD FOR PRODUCING L-FUCULOSE AND METHOD FOR PRODUCING L-FUCOSE | AJINOMOTO CO., INC. (JP) | 2007-02-01 | — | — | US | disclosed |
| EP-1743943-A1 | PROCESS FOR PRODUCING L-FUCULOSE AND PROCESS FOR PRODUCING L-FUCOSE | Ajinomoto Co., Inc. (JP) | 2007-01-17 | — | — | EP | disclosed |
| US-20010036654-A1 | Canola acetyl-CoA carboxylase compositions and methods of use | ARCH DEVELOPMENT CORPORATION (US) | 2001-11-01 | — | — | US | disclosed |
| US-6177267-B1 | AMINO ACID SEQUENCE OF ACETYL-COENZYME A CARBOXYLASE; FOR TRANSGENIC PLANTS WITH INCREASED OR DECREASED HERBICIDE RESISTANCE; FOR SCREENING SAMPLES FOR HERBICIDE RESISTANCE | ARCH DEVELOPMENT CORP. | 2001-01-23 | — | — | US | disclosed |
| US-5910626-A | NUCLEIC ACIDS ENCODING POLYPEPTIDES PARTICIPATING IN THE CARBOXYLATION OF ACETYL-COA, E.G. A SUBUNIT, BIOTIN CARBOXYLASE CARRIER PROTEIN; HERBICIDE RESISTANCE; INCREASED OIL PRODUCTION IN PLANT TISSUE | ARCH DEVELOPMENT CORPORATION (US) | 1999-06-08 | — | — | US | disclosed |
| US-5801233-A | DNA SEGMENTS AND CELLS FOR ACETYL COA CARBOXYLASE AND NUCLEIC ACID SEGMENTS | ARCH DEVELOPMENT CORPORATION (US) | 1998-09-01 | — | — | US | disclosed |
| EP-0820514-A2 | ACETYL-CoA CARBOXYLASE COMPOSITIONS AND METHODS OF USE | ARCH DEVELOPMENT CORPORATION (US) | 1998-01-28 | — | — | EP | disclosed |
| WO-1996032484-A2 | ACETYL-CoA CARBOXYLASE COMPOSITIONS AND METHODS OF USE | ARCH DEVELOPMENT CORPORATION (US) | 1996-10-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230127229-A1 | MULTI-AZIRIDINE COMPOUND | HRH3, QDPR, HRH4 | CXCR4 1017/4885CXCL12 4200/4885KMT2A 974/4885 |
| US-20230054196-A1 | MULTI-AZIRIDINE COMPOUND | HRH3, QDPR, HRH4 | CXCR4 1204/4885CXCL12 4456/4885KMT2A 1179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.